Calendar Doximity, Inc.

Equities

DOCS

US26622P1075

Real-time Estimate Cboe BZX 12:17:58 2024-04-23 pm EDT 5-day change 1st Jan Change
24.88 USD +0.36% Intraday chart for Doximity, Inc. -0.88% -11.41%

Chart calendar Doximity, Inc.

1f048ad7100eec601f52915e3432.m2N9V14s3CmgqliV0u4xeJED6tzZiqwzt0NNjtAoyTo.81o5EycVrnGRnWj4ir9cK_5KoJ6bx8hkzycK5uhZuUDOEwUZK3Ppa8f5GQ~b122cca3f2545ee953d22fe5ed516820

Upcoming events on Doximity, Inc.

2024-05-13 Q4 2024 Earnings Release (Projected)
2024-08-05 Q1 2025 Earnings Release (Projected)
2024-11-06 Q2 2025 Earnings Release (Projected)
2025-02-05 Q3 2025 Earnings Release (Projected)

Past events on Doximity, Inc.

2024-03-13 11:15 am Barclays Global Healthcare Conference
2024-03-05 02:50 pm Raymond James Institutional Investors Conference
2024-02-08 05:00 pm Q3 2024 Earnings Call
2024-02-08 04:01 pm Q3 2024 Earnings Release
2023-11-09 05:00 pm Q2 2024 Earnings Call
2023-11-09 04:01 pm Q2 2024 Earnings Release
2023-08-08 05:00 pm Q1 2024 Earnings Call
2023-08-08 04:01 pm Q1 2024 Earnings Release
2023-07-26 12:00 pm Annual General Meeting
2023-06-08 11:00 am William Blair Growth Stock Conference
2023-06-06 10:30 am Investor Day
2023-05-16 05:00 pm Q4 2023 Earnings Call
2023-05-16 04:01 pm Q4 2023 Earnings Release
2023-03-08 09:15 am Raymond James Institutional Investors Conference
2023-02-09 05:00 pm Q3 2023 Earnings Call
2023-02-09 04:01 pm Q3 2023 Earnings Release
2022-12-05 10:20 am Raymond James Technology Investors Conference
2022-11-10 05:00 pm Interim 2023 Earnings Call
2022-11-10 04:01 pm Interim 2023 Earnings Release
2022-08-04 05:00 pm Q1 2023 Earnings Call

Annual results

Fiscal PeriodMarch 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


344
340
1.08%
419
418
0.21%

474

EBITDA
Million USD
Released
Forecast
Spread
0,00


150
146
2.74%
184
181
1.76%

225

EBIT
Million USD
Released
Forecast
Spread
0,00


146
142
3.14%
178
175
2.17%

219

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


114
109
4.46%
133
128
3.65%

178

Net income
Million USD
Released
Forecast
Spread
21,6


133
135
-0.98%
113
106
6.17%

137

EPS
USD
Released
Forecast
Spread
0,45


0,70
0,71
-1.58%
0,53
0,50
6.37%

0,67

Announcement Date28/05/2117/05/2216/05/23-

Quarterly results

Fiscal PeriodMarzo 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
97,9
86,3
13.45%
93,7
90,2
3.87%
90,6
89,7
1.1%
102
100
1.83%
115
111
3.4%
111
110
0.79%
108
107
1.35%
114
109
4.14%
135
127
6.11%

116


119


125


146


130

EBITDA
Million USD
Released
Forecast
Spread
47,0
32,6
44.06%
39,4
35,0
12.49%
33,5
29,2
14.98%
46,0
40,3
14.09%
55,5
48,4
14.62%
48,9
45,7
7.01%
46,6
39,5
17.82%
54,2
44,8
20.94%
73,3
61,7
18.77%

51,1


53,0


58,3


73,1


58,6

EBIT
Million USD
Released
Forecast
Spread
45,9
31,5
45.76%
38,2
34,1
12.04%
32,4
28,6
13.3%
44,6
38,9
14.74%
54,1
46,8
15.44%
47,4
43,8
8.17%
45,2
37,9
19.14%
51,6
43,8
17.75%
71,8
59,6
20.46%

49,2


52,4


57,2


71,7


54,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
35,8
23,1
54.91%
27,9
23,5
18.94%
22,5
17,1
31.53%
33,0
28,8
14.77%
40,9
34,9
17.36%
36,7
31,9
15.14%
34,5
26,2
31.65%
39,7
30,9
28.66%
63,0
51,9
21.43%

40,4


41,7


48,3


62,8


49,5

Net income
Million USD
Released
Forecast
Spread
55,6
21,2
162.09%
36,7
25,3
45.42%
22,4
14,9
49.88%
26,3
25,4
3.35%
33,5
29,1
15.14%
30,7
26,4
16.27%
28,4
21,5
31.84%
30,6
25,2
21.42%
48,0
39,8
20.62%

30,5


31,1


36,1


46,9


36,9

EPS
USD
Released
Forecast
Spread
0,26
0,10
154.68%
0,17
0,12
44.68%
0,10
0,07
38.47%
0,12
0,12
-0.92%
0,16
0,14
16.13%
0,14
0,12
14.02%
0,13
0,10
28.71%
0,15
0,12
20.26%
0,24
0,20
20.17%

0,16


0,16


0,19


0,24


0,19

Announcement Date08/02/2217/05/2204/08/2210/11/2209/02/2316/05/2308/08/2309/11/2308/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DOCS Stock
  4. Calendar Doximity, Inc.